The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
I think the data uh suggests you're getting most of the value by about 10 milligrams. So once you go to 12.5 and 15, which are the two highest doses, you're still getting a benefit. Um, but it's, you know, it's like most drugs, you're getting most of the benefit at the lowest dose. So 5 to 7.5 milligrams of trespide is probably where you're getting the majority of the dose.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
Um, I think the data uh suggests you're getting most of the value by about 10 milligrams. So once you go to 12.5 and 15, which are the two highest doses, you're still getting a benefit. Um, but it's, you know, it's like most drugs, you're getting most of the benefit at the lowest dose. So 5 to 7.5 milligrams of tracepide is probably where you're getting the majority of the dose.
Our view in this is we want the patient to be on the lowest dose possible and take as long as necessary to get there.